Read More 1 minute read Funding News News Elegen Secures $35M in Series B for DNA Synthesis Key Highlights $35 million Series B round led by Triatomic Capital, featuring GSK and John Ballantyne. Investment to expand ENFINIA™… byChris-Anne RoqueMay 15, 2024
Read More 1 minute read Funding News News Zafrens Secures $23 Million in Funding to Advance High-Resolution Drug Discovery with Z-Screen™ Platform Key Highlights Zafrens raises $23 million in financing, led by Prime Movers Lab and supported by various investors including… byChris-Anne RoqueDecember 13, 2023